CDC Statement on IPERGAY Trial of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention among Men Who Have Sex with Men
Archive - Health
The results, which are based on a published study in The Journal of Sexual Medicine, are presented on an interactive site that’s as fun to play with as it is informative.
Used as a long-lasting injectable treatment for HIV-infected people, Cabotegravir, along with another drug, Rilpivarine, is expected to enter phase III trials early next year.
I don’t think the LGBT community, or people with HIV, have gotten the credit we deserve for what we did in those early years. How we came together to love and care for each other was something remarkable.